Facebook page "JSP Pharma - JP สุภาพโอสถ70ปี" impersonates "JSP Pharmaceutical Manufacturing (Thailand) Plc." : Unlicensed securities and derivatives business (Disclosure Date : 05/03/2025)
decelerating rate due to slowdown in external sector and manufacturing production at home. Meanwhile, private consumption which continued to expand was derived mainly from increased expenditures on automobiles
volatile during this quarter. However, Thailand’s financial stability was satisfactory due to a high current account surplus and rising demand for imported raw materials used in export-oriented manufacturing
capital outflows from the Thai market. Given the healthy Thai economic fundamentals, as evidenced by revived economic activity, a rising inflation rate and current account surplus, however, Thailand may
ก () (LPN https://market.sec.or.th/PUBLIC/MRAP/MRAPFile.aspx?FILESEQUENCE=0&FUNDNAME=TISESG&FUNDCOMPRUNCODE=MF... 22012327.pdf ., manufacturing, property , and logistics. EBITDA expands in low-single
inflows into Thailand thanks to its economic stability, as evidenced by an ongoing current account surplus – albeit at a decelerating rate amid the global trade slowdown, as well as the relentless rise of
may result in ongoing financial market volatility, perhaps leading to capital outflows. Still, Thailand’s healthy fundamentals, as evidenced by low foreign debts, high current account surplus and
%, followed by manufacturing and commerce sector at 21.1% and housing loans sector at 19.6% of total loans. Big Corporate & Corporate As of 30 June 2017, the bank had total loans to customers of Big Corporate
15.7% of total loans. When classified by type of business loans, the most portion of them was public utilities and services at 26.8%, followed by manufacturing and commerce sector at 22.2% and financial